JP2022522815A5 - - Google Patents
Info
- Publication number
- JP2022522815A5 JP2022522815A5 JP2021551926A JP2021551926A JP2022522815A5 JP 2022522815 A5 JP2022522815 A5 JP 2022522815A5 JP 2021551926 A JP2021551926 A JP 2021551926A JP 2021551926 A JP2021551926 A JP 2021551926A JP 2022522815 A5 JP2022522815 A5 JP 2022522815A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- sequence number
- composition according
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962817152P | 2019-03-12 | 2019-03-12 | |
| US62/817,152 | 2019-03-12 | ||
| PCT/CA2020/050321 WO2020181376A1 (en) | 2019-03-12 | 2020-03-11 | Tsg-6 antibodies and uses therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022522815A JP2022522815A (ja) | 2022-04-20 |
| JP2022522815A5 true JP2022522815A5 (cg-RX-API-DMAC7.html) | 2023-03-20 |
Family
ID=72427149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021551926A Pending JP2022522815A (ja) | 2019-03-12 | 2020-03-11 | Ｔｓｇ－６抗体およびその用途 |
Country Status (14)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023192829A2 (en) * | 2022-03-28 | 2023-10-05 | University Of Florida Research Foundation, Incorporated | Alpha-1 antitrypsin z- and m-specific binding proteins |
| TWI876557B (zh) * | 2022-09-30 | 2025-03-11 | 臺北醫學大學 | 用於前列腺癌診斷和早期發病的單株抗體 |
| KR102582500B1 (ko) | 2022-10-27 | 2023-09-26 | 서울대학교산학협력단 | Tnfaip6 -조작된 종양 세포 및 이의 이용 |
| WO2024102759A1 (en) * | 2022-11-07 | 2024-05-16 | Board Of Regents, The University Of Texas System | Methods involving detecting tnf stimulated gene 6 (tsg-6) for improving anti-tumor responses to immune therapy in cancer patients |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2896058A1 (en) * | 2012-12-24 | 2014-07-03 | Abbvie Inc. | Prolactin receptor binding proteins and uses thereof |
| AU2015301338C1 (en) * | 2014-08-04 | 2021-07-22 | Baylor Research Institute | Antagonistic anti-OX40L antibodies and methods of their use |
| PT3186281T (pt) * | 2014-08-28 | 2019-07-10 | Halozyme Inc | Terapia de combinação com uma enzima de degradação de hialuronano e um inibidor de pontos de verificação imunológica |
-
2020
- 2020-03-11 US US17/434,368 patent/US20220153834A1/en not_active Abandoned
- 2020-03-11 CA CA3129302A patent/CA3129302A1/en active Pending
- 2020-03-11 JP JP2021551926A patent/JP2022522815A/ja active Pending
- 2020-03-11 KR KR1020217032689A patent/KR20210138674A/ko not_active Ceased
- 2020-03-11 SG SG11202109708T patent/SG11202109708TA/en unknown
- 2020-03-11 AU AU2020234533A patent/AU2020234533A1/en active Pending
- 2020-03-11 MX MX2021010766A patent/MX2021010766A/es unknown
- 2020-03-11 TW TW109108016A patent/TW202100551A/zh unknown
- 2020-03-11 WO PCT/CA2020/050321 patent/WO2020181376A1/en not_active Ceased
- 2020-03-11 EA EA202192488A patent/EA202192488A1/ru unknown
- 2020-03-11 BR BR112021017810A patent/BR112021017810A2/pt unknown
- 2020-03-11 CN CN202080028139.0A patent/CN113748130A/zh active Pending
- 2020-03-11 EP EP20769649.3A patent/EP3938389A4/en not_active Withdrawn
-
2021
- 2021-09-09 IL IL286216A patent/IL286216A/en unknown